Delayed diagnoses of Turner's syndrome:: Proposed guidelines for change

被引:130
作者
Sävendahl, L
Davenport, ML
机构
[1] Univ N Carolina, Div Endocrinol, Dept Pediat, Chapel Hill, NC 27599 USA
[2] Karolinska Inst, Dept Woman & Child Hlth, Pediat Endocrinol Unit, Stockholm, Sweden
关键词
D O I
10.1067/mpd.2000.107390
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To measure the delays in diagnosis of Turner's syndrome (TS) and to propose strategies for earlier screening and diagnosis. Methods: The medical records of 81 girls with TS were reviewed for age at diagnosis, reason(s) for karyotype analysis, and clinical features including growth failure. Delay in diagnosis was calculated as equal to age at diagnosis for children born with lymphedema and/or 2 or more of the following dysmorphic features: webbed neck, nail dysplasia, high palate, and short fourth metacarpal. For all others, delay in diagnosis was calculated as the difference between the age at which height fell below the 5th per centile and the age at which the diagnosis of TS was made. Results: Lymphedema was the key to diagnosis in 97% of the girls diagnosed with TS in infancy, and short stature was die key to diagnosis for 82% of the girls diagnosed in childhood or adolescence. For girls diagnosed in childhood or adolescence, the delay in diagnosis averaged 7.7 +/- 5.4 years. Many hall dysmorphic features and/or a history of lymphedema at birth, and diagnosis was made an average of 5.3 years after patients had fallen below the 5th percentile for height. By the time of diagnosis, patients were very short, aver aging -2.9 SD in height. Conclusions: The diagnosis of TS is often delay ed. We recommend karyotype analysis for all girls with unexplained short stature, delayed puberty, webbed neck, lymphedema, or coarctation of the aorta. Furthermore , karotype analysis st-could be strongly considered for those who remain above the 5th percentile for height but have 2 or more features of TS, including high palate, nail dysplasia, short fourth metacarpal, and strabismus.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 29 条
[1]  
CANKI N, 1988, ANN GENET-PARIS, V31, P4
[2]  
CHROUSOS GA, 1984, OPHTHALMOLOGY, V91, P926
[3]   Turner syndrome: a pattern of early growth failure [J].
Davenport, ML ;
Punyasavatsut, N ;
Gunther, D ;
Savendahl, L ;
Stewart, PW .
ACTA PAEDIATRICA, 1999, 88 :118-121
[4]   Growth hormone therapy in Turner syndrome - Current uncertainties and future strategies [J].
Donaldson, MDC .
HORMONE RESEARCH, 1997, 48 :35-44
[5]   Assessment of Turner's syndrome by molecular analysis of the X chromosome in growth-retarded girls [J].
Gicquel, C ;
Gaston, V ;
Cabrol, S ;
Le Bouc, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1472-1476
[6]   Prenatal and postnatal prevalence of Turner's syndrome: A registry study [J].
Gravholt, CH ;
Juul, S ;
Naeraa, RW ;
Hansen, J .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 312 (7022) :16-21
[7]   Morbidity in Turner Syndrome [J].
Gravholt, CH ;
Juul, S ;
Naeraa, RW ;
Hansen, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (02) :147-158
[8]   PHYSICAL GROWTH - NATIONAL-CENTER-FOR-HEALTH-STATISTICS PERCENTILES [J].
HAMILL, PVV ;
DRIZD, TA ;
JOHNSON, CL ;
REED, RB ;
ROCHE, AF ;
MOORE, WM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (03) :607-629
[9]   TURNER SYNDROME - FINAL HEIGHT, GLUCOSE-TOLERANCE, BONE-DENSITY AND PSYCHOSOCIAL STATUS IN 25 ADULT PATIENTS [J].
HOLL, RW ;
KUNZE, D ;
ETZRODT, H ;
TELLER, W ;
HEINZE, E .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (01) :11-16
[10]   THE DISTRIBUTION OF CHROMOSOMAL GENOTYPES ASSOCIATED WITH TURNERS SYNDROME - LIVEBIRTH PREVALENCE RATES AND EVIDENCE FOR DIMINISHED FETAL MORTALITY AND SEVERITY IN GENOTYPES ASSOCIATED WITH STRUCTURAL-X ABNORMALITIES OR MOSAICISM [J].
HOOK, EB ;
WARBURTON, D .
HUMAN GENETICS, 1983, 64 (01) :24-27